Cardiac Surgery Clinical Trial
Official title:
Pecto-Intercostal Fascial Plane Block for Enhanced Recovery After Cardiac Surgery
Verified date | January 2024 |
Source | University of Wisconsin, Madison |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is being done to see if bilateral pecto-intercostal fascial plane blocks (PIFB) with a mixture of liposomal and standard bupivacaine decrease pain and opioid requirements in patients undergoing cardiac surgery via median sternotomy compared to controls (sham blocks with saline). 100 participants will be recruited and can expect to be on study for 100 days.
Status | Completed |
Enrollment | 100 |
Est. completion date | November 30, 2023 |
Est. primary completion date | September 3, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Participant provides consent to participate in study - Ideal body weight (IBW) is >50kg - Participant is planned to undergo coronary artery bypass graft or single valve repair/replacement surgery via median sternotomy - Participant is undergoing an elective procedure Exclusion Criteria: - Participant is unable or unwilling to give consent - Non-English speaking - Known or believed to be pregnant or is currently breastfeeding - Participant is a prisoner - Clinically unstable per discretion of the Investigator - Participant requires urgent/emergent surgery - History of previous sternotomy - Preoperative coagulopathy (INR >1.4, platelets <100,000) or ongoing anticoagulation or anti-platelet therapy (except aspirin 81mg) - Allergy or sensitivity to amide-type local anesthetics, dexmedetomidine or ketamine - Participant has decompensated heart failure - Severe left ventricle dysfunction (defined quantitatively as an ejection fraction of less than or equal to 35%) or right ventricle dysfunction (defined qualitatively as "severe") - Diagnosis of cirrhosis or end-stage liver disease - Requires the use of mechanical circulatory support pre-operatively - Participant uses chronic opioids (meaning at the time of the preoperative screening evaluation by the study team, the patient is prescribed and taking any opioid pain medication) |
Country | Name | City | State |
---|---|---|---|
United States | University of Wisconsin Hospital and Clinics | Madison | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
University of Wisconsin, Madison |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total Opioid Consumption 72 hours postoperatively | Total opioid consumption during the initial 72 hours postoperatively will be measured in morphine equivalents and compared between groups. | up to 72 hours post-op | |
Secondary | Total Intraoperative Opioid Consumption | Total intraoperative opioid consumption will be measured in morphine equivalents and compared between groups. | intraoperative | |
Secondary | Daily Mean Pain Scores first 72 hours Postoperatively | Pain will be assessed, according to standard of care, every 4 hours using the 11-point Numerical Rating Scale (NRS), beginning at time 0 (arrival to ICU). Each patient's pain scores (higher scores indicate worse pain) within each postoperative day will be averaged, and the mean pain scores during each day and throughout the first 72 hours will be compared between the intervention and control groups. | up to 72 hours post-op | |
Secondary | Maximum Pain Scores up to 72 hours Postoperatively | Pain will be assessed, according to standard of care, every 4 hours using the 11-point Numerical Rating Scale (NRS) where higher score indicate worse pain, beginning at time 0 (arrival to ICU). Maximum pain scores will be compared between groups. | up to 72 hours post-op | |
Secondary | Pain Score at 90 days Postoperatively | Pain will be assessed, according to standard of care, every 4 hours using the 11-point Numerical Rating Scale (NRS) where higher score indicate worse pain. Pain at 90 days postoperative will be surveyed by phone. | up to 90 days post-op | |
Secondary | Daily Opioid Consumption up to 72 hours Postoperatively | Daily opioid consumption during the initial 72 hours postoperatively will be measured in morphine equivalents and compared between groups. | up to 72 hours post-op | |
Secondary | Hours of Mechanical Ventilation after ICU admission | Duration of mechanical ventilation will be measured by hours of mechanical ventilation after admission to the ICU. | up to 72 hours post-op | |
Secondary | Number of postoperative days until the first Bowel Movement | Return of bowel function will be measured in the number of postoperative days until the first bowel movement. | up to 72 hours post-op | |
Secondary | Incidence of Postoperative Delirium per the Confusion Assessment Method for the ICU (CAM-ICU) | Postoperative delirium will be measured according to standard of care by utilizing the CAM-ICU assessment every 8-12 hours. The CAM-ICU determines either 'yes' or 'no' the participant is experiencing delirium. | up to 72 hours post-op | |
Secondary | Number of Hours that the Patient is in the ICU | Duration of ICU stay will be measured by the number of hours that the patient is in the ICU until an order is placed for transfer to a lower level of care. | up to 72 hours post-op | |
Secondary | Number of post-operative days until the Patient is Discharged | Duration of hospital stay will be measured by the number of post-operative days until the patient is discharged. | up to 7 days | |
Secondary | Number of Participants Using Opioids at 90 days Postoperatively | Patient use of opioids at 90 days will be obtained by phone call. | up to 90 days post-op |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054179 -
Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04051021 -
Non-Pharmacological Interventions on Patient Experience and Healthcare Utilization in Adult Cardiac Surgery Patients
|
N/A | |
Recruiting |
NCT04604886 -
The Consistency of Cardiac Output Measured by Pulmonary Artery Catheter and LiDCO in Cardiac Surgical Patients
|
N/A | |
Recruiting |
NCT04075981 -
Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
|
Phase 3 | |
Completed |
NCT04062396 -
Comparison of Remowell 2 and Inspire on Delirium and Cognitive Dysfunction
|
N/A | |
Recruiting |
NCT04709705 -
DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05563662 -
SURgical Registry of ENDocarditis EuRope
|
||
Withdrawn |
NCT03289104 -
Improving Sternal Healing After Cardiac Surgery: Sternal Wire vs ZIPFIX
|
N/A | |
Completed |
NCT02964026 -
Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients
|
N/A | |
Completed |
NCT03563196 -
Diagnosis Of Pulmonary Complications After Cardiac Surgery In Children
|
||
Completed |
NCT04199039 -
Effects of Endotracheal Tube Fixation Methods on Hemodynamic Parameters During Endotracheal Suction
|
N/A | |
Completed |
NCT02471001 -
The Levels of Anaesthetics in Heart Muscle During Heart Surgery
|
N/A | |
Completed |
NCT02325726 -
RRI Compared With NephroCheckTM to Predict Acute Renal Failure After Cardiac Surgery.
|
N/A | |
Completed |
NCT01246947 -
Tricuspid Annuloplasty for Moderate Tricuspid Regurgitation Associated With Miral Operation
|
N/A | |
Completed |
NCT01151254 -
Comparison of Propofol Based Versus Volatile Based Anesthesia and Postoperative Sedation
|
N/A | |
Completed |
NCT00996099 -
Continuous Glucose Monitoring Combined With Computer Algorithm for Intensive Insulin Therapy in Cardiosurgical Patients
|
N/A | |
Completed |
NCT00821262 -
Sevoflurane in Cardiac Surgery
|
Phase 4 | |
Completed |
NCT00617955 -
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
|
N/A | |
Completed |
NCT00337805 -
Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery
|
Phase 2/Phase 3 | |
Completed |
NCT00336466 -
The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS)
|
Phase 2 |